Survival assessment and pre-diagnostic risk factors for lung cancer incidence: Insights from the Golestan Cohort Study. Mousavi SF, Masoudi S, Rezaei N, Pourghazi F, et al. PLoS One 2025;20:e0320931.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mousavi SF, Masoudi S, Rezaei N, Pourghazi F, et al. Survival assessment and pre-diagnostic risk factors for lung cancer incidence: Insights from the Golestan Cohort Study. PLoS One 2025;20:e0320931.
PMID: 40299810